"From high quality medical services to nationally renowned medical education and residency programs, Methodist Dallas Medical Center is a leading healthcare resource in North Texas. Our hospital features private rooms, 585 beds, and more than 250 highly skilled physicians. Time and again we have been recognized for our high standards of care for heart attack, heart failure, pneumonia, stroke, and other medical issues that require expert-level treatment."

During the past decade, Methodist Health System Clinical Research Institute conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Methodist Health System Clinical Research Institute" #1 sponsor was "Methodist Health System" with 2 trials, followed by "Target PharmaSolutions, Inc." with 2 trials sponsored, "C. R. Bard" with 1 trials sponsored, "Conatus Pharmaceuticals Inc." with 1 trials sponsored and "Daniel Benjamin" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Methodist Health System Clinical Research Institute" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "National Center for Advancing Translational Sciences (NCATS)" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Methodist Health System Clinical Research Institute" are "Arterial Occlusive Diseases" (1 trials), "Cirrhosis" (1 trials), "Covid19" (1 trials), "Decompensated Cirrhosis" (1 trials) and "Fracture" (1 trials). Many other conditions were trialed in "Methodist Health System Clinical Research Institute" in a lesser frequency.

Most popular intervention types in "Methodist Health System Clinical Research Institute" are "Other" (3 trials), "Drug" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abatacept" (1 trials), "Emricasan (25 mg)" (1 trials), "Emricasan (5 mg)" (1 trials), "Fracture" (1 trials) and "HIV D+/R+" (1 trials). Other intervention names were less common.

The vast majority of trials in "Methodist Health System Clinical Research Institute" are 8 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Methodist Health System Clinical Research Institute". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Methodist Health System Clinical Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Methodist Health System Clinical Research Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".